Imagen Therapeutics Limited

The predictTx platform is Imagen’s suite of in-vitro pharmacology services for the oncology drug discovery and development community. By harnessing the power of our biobank, with 100’s of clinically relevant 2D and 3D patient derived cell (PDC) models recapitulating the phenotype and genotype of parent tumours. We offer access to an unrivalled breadth of PDC models and related data, and can help you make rapid, informed decisions on which investigational compounds to progress.

Request more information

Company Name

Imagen Therapeutics Limited


0161 826 4030


Unit 2 & 2a Enterprise House,
Llloyd Street North
M15 6SE

Association Memberships

Skip to toolbar